See more : HealthCo Healthcare and Wellness REIT (HCW.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Cosmax, Inc. (192820.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cosmax, Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Fulgent Sun International (Holding) Co., Ltd. (9802.TW) Income Statement Analysis – Financial Results
- G M Polyplast Limited (GMPL.BO) Income Statement Analysis – Financial Results
- Benton Resources Inc. (BNTRF) Income Statement Analysis – Financial Results
- 360 Ludashi Holdings Limited (3601.HK) Income Statement Analysis – Financial Results
- Selected Investments Equities (SIIEQT.CO) Income Statement Analysis – Financial Results
Cosmax, Inc. (192820.KS)
About Cosmax, Inc.
Cosmax, Inc. researches, develops, produces, and sells cosmetic, health function food, and pharmaceutical products in Korea and internationally. The company offers skincare, color cosmetics, and hair care products, as well as mask sheets and eye patches. It also develops and manufactures medical supplies and devices; raw materials for cosmetic products; and functional containers and filling packaging products for cosmetics. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,777.49B | 1,600.13B | 1,591.49B | 1,382.88B | 1,330.65B | 1,259.72B | 883.95B | 756.96B | 533.34B | 336.23B |
| Cost of Revenue | 1,409.88B | 1,394.86B | 1,313.98B | 1,172.04B | 1,147.18B | 1,105.01B | 772.05B | 638.86B | 445.21B | 279.79B |
| Gross Profit | 367.61B | 205.27B | 277.51B | 210.84B | 183.47B | 154.71B | 111.90B | 118.11B | 88.14B | 56.44B |
| Gross Profit Ratio | 20.68% | 12.83% | 17.44% | 15.25% | 13.79% | 12.28% | 12.66% | 15.60% | 16.53% | 16.78% |
| Research & Development | 85.72B | 76.17B | 70.26B | 54.27B | 910.33K | 42.35B | 33.36B | 0.00 | 0.00 | 0.00 |
| General & Administrative | 12.93B | 10.64B | 10.37B | 11.59B | 11.00B | 11.51B | 7.35B | 6.19B | 5.37B | 3.22B |
| Selling & Marketing | 56.93B | 56.49B | 54.24B | 59.00B | 49.23B | 44.42B | 35.85B | 30.37B | 23.80B | 14.58B |
| SG&A | 167.01B | 67.13B | 64.60B | 70.59B | 60.23B | 55.93B | 43.20B | 36.55B | 29.17B | 17.80B |
| Other Expenses | 0.00 | 85.04B | 90.31B | 73.61B | 69.24B | 2.20B | 2.31B | 985.05M | 964.16M | 1.11B |
| Operating Expenses | 177.96B | 152.17B | 154.91B | 144.20B | 129.47B | 102.37B | 76.76B | 65.49B | 52.20B | 32.10B |
| Cost & Expenses | 1,661.81B | 1,547.02B | 1,468.89B | 1,316.24B | 1,276.66B | 1,207.38B | 848.81B | 704.35B | 497.41B | 311.89B |
| Interest Income | 6.52B | 2.44B | 3.96B | 1.32B | 730.97M | 266.76M | 237.46M | 203.68M | 215.70M | 142.53M |
| Interest Expense | 32.11B | 20.97B | 17.51B | 20.04B | 22.64B | 18.50B | 9.33B | 6.89B | 5.69B | 4.07B |
| Depreciation & Amortization | 59.43B | 58.68B | 51.67B | 45.70B | 37.99B | 25.28B | 20.23B | 12.55B | 9.12B | 6.58B |
| EBITDA | 175.77B | 86.04B | 147.49B | 66.55B | 96.62B | 80.02B | 54.83B | 65.89B | 44.31B | 32.70B |
| EBITDA Ratio | 9.89% | 7.10% | 10.56% | 8.26% | 7.27% | 6.36% | 6.20% | 8.69% | 8.31% | 9.73% |
| Operating Income | 115.69B | 53.10B | 122.60B | 66.64B | 54.00B | 52.34B | 35.14B | 52.62B | 35.93B | 24.34B |
| Operating Income Ratio | 6.51% | 3.32% | 7.70% | 4.82% | 4.06% | 4.15% | 3.98% | 6.95% | 6.74% | 7.24% |
| Total Other Income/Expenses | -31.46B | -46.93B | -44.33B | -66.53B | -18.07B | -16.10B | -9.88B | -6.13B | -6.44B | -2.29B |
| Income Before Tax | 84.22B | 6.17B | 78.27B | 113.35M | 35.93B | 36.24B | 25.26B | 46.49B | 29.49B | 22.05B |
| Income Before Tax Ratio | 4.74% | 0.39% | 4.92% | 0.01% | 2.70% | 2.88% | 2.86% | 6.14% | 5.53% | 6.56% |
| Income Tax Expense | 46.42B | 22.62B | 43.93B | 29.17B | 17.61B | 15.17B | 9.74B | 15.05B | 10.61B | 6.29B |
| Net Income | 57.14B | -16.45B | 34.34B | -29.05B | 18.32B | 32.62B | 18.86B | 34.78B | 21.24B | 16.61B |
| Net Income Ratio | 3.21% | -1.03% | 2.16% | -2.10% | 1.38% | 2.59% | 2.13% | 4.59% | 3.98% | 4.94% |
| EPS | 5.04K | -1.45K | 3.20K | -2.84K | 1.79K | 3.19K | 1.84K | 3.79K | 2.27K | 1.78K |
| EPS Diluted | 5.04K | -1.45K | 3.20K | -2.84K | 1.79K | 3.19K | 1.84K | 3.79K | 2.27K | 1.78K |
| Weighted Avg Shares Out | 11.35M | 11.35M | 10.72M | 10.22M | 10.22M | 10.22M | 10.22M | 9.18M | 9.35M | 9.35M |
| Weighted Avg Shares Out (Dil) | 11.35M | 11.35M | 10.72M | 10.22M | 10.22M | 10.22M | 10.22M | 9.18M | 9.35M | 9.35M |
Source: https://incomestatements.info
Category: Stock Reports